We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.68B
AUM Growth
-$7.95M
Cap. Flow
+$55.2M
Cap. Flow %
3.28%
Top 10 Hldgs %
17.16%
Holding
515
New
107
Increased
139
Reduced
156
Closed
69

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
RACE icon
Ferrari
RACE
+$26.2M
3
DINO icon
HF Sinclair
DINO
+$10.4M
4
PFE icon
Pfizer
PFE
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.95M

Sector Composition

Rank Sector Weight
1 Healthcare 24.95%
2 Technology 20.52%
3 Consumer Discretionary 16.46%
4 Industrials 8.03%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
401
DELISTED
Myovant Sciences Ltd.
MYOV
$226K 0.01%
+43,464
New +$322K
ONDK
402
DELISTED
On Deck Capital, Inc.
ONDK
$226K 0.01%
67,400
OOMA icon
403
Ooma
OOMA
$564M
$223K 0.01%
21,397
+4,597
+27% +$53.8K
GNMK
404
DELISTED
GenMark Diagnostics, Inc
GNMK
$218K 0.01%
36,000
BKCC
405
DELISTED
BlackRock Capital Investment Corporation
BKCC
$216K 0.01%
43,200
+10,024
+30% +$55.3K
HONE
406
DELISTED
HarborOne Bancorp
HONE
$213K 0.01%
+21,200
New +$219K
ALLY icon
407
Ally Financial
ALLY
$13.3B
$212K 0.01%
+6,400
New +$207K
GOGL
408
DELISTED
Golden Ocean Group
GOGL
$211K 0.01%
36,200
+8,200
+29% +$50K
EGAN icon
409
eGain
EGAN
$183M
$210K 0.01%
+26,209
New +$201K
RCUS icon
410
Arcus Biosciences
RCUS
$3.54B
$210K 0.01%
23,100
+6,400
+38% +$51.4K
ARD
411
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$208K 0.01%
13,246
+46
+0.3% +$789
AMRC icon
412
Ameresco
AMRC
$1.12B
$206K 0.01%
12,842
RLGT icon
413
Radiant Logistics
RLGT
$416M
$200K 0.01%
38,773
+14,349
+59% +$74.6K
BFIN
414
DELISTED
BankFinancial
BFIN
$192K 0.01%
16,100
-400
-2% -$5.02K
RYZ
415
Ryerson Holding Corp
RYZ
$1.6B
$189K 0.01%
22,100
+5,000
+29% +$39.3K
PGNX
416
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$183K 0.01%
36,281
-103,619
-74% -$517K
SPOK icon
417
Spok Holdings
SPOK
$226M
$180K 0.01%
15,103
+4,032
+36% +$52.1K
SYRS
418
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$166K 0.01%
1,603
-417
-21% -$39.4K
AIRG icon
419
Airgain
AIRG
$71.4M
$165K 0.01%
14,000
+2,800
+25% +$34.8K
DGII icon
420
Digi International
DGII
$2.5B
$165K 0.01%
12,100
-10,033
-45% -$132K
DSPG
421
DELISTED
DSP Group Inc
DSPG
$165K 0.01%
11,700
NEXA icon
422
Nexa Resources
NEXA
$1.67B
$164K 0.01%
17,400
-1,456
-8% -$13K
BCOV
423
DELISTED
Brightcove, Inc.
BCOV
$162K 0.01%
15,500
+3,500
+29% +$40.3K
CAMT icon
424
Camtek
CAMT
$6.85B
$151K 0.01%
16,100
-6,800
-30% -$62.2K
LFVN icon
425
LifeVantage
LFVN
$79.2M
$141K 0.01%
+10,289
New +$125K

Similar funds

PDT Partners's Q3 2019 Portfolio in Review

As of Q3 2019, PDT Partners held 515 positions worth $1.68B, down 0.47% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners deployed $55.2M of net new capital in Q3 2019, opening 107 new positions and adding to 139 existing holdings. Its largest new stake was Linde: 238,663 shares worth $46.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $51.3M trimmed.

  • PDT Partners's largest Q3 2019 buy was Linde: 238,663 shares worth $46.2M.
  • PDT Partners added most to Ferrari in Q3 2019, an estimated $26.2M increase.
  • PDT Partners's biggest Q3 2019 reduction was AbbVie, cutting an estimated $51.3M.
  • PDT Partners fully exited Mettler-Toledo International in Q3 2019, selling an estimated $37.2M.
  • PDT Partners's ten largest holdings make up 17% of its $1.68B portfolio in Q3 2019.
  • PDT Partners opened 107 new positions and closed 69 in Q3 2019.
  • PDT Partners's portfolio value fell 0.47% quarter-over-quarter to $1.68B.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.